Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Factors Affecting SARS-CoV-2 Vaccination Intent and Decision Making Among African American, Native American, and Hispanic Participants in a Qualitative Study.
Journal: Public health reports (Washington, D.C. : 1974)
Published: March 27, 2023
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: August 29, 2022
COVID-19 Vaccination Status, Attitudes, and Values among US Adults in September 2021.
Journal: Journal of clinical medicine
Published: June 03, 2022
COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021.
Journal: Vaccine
Published: April 11, 2022
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
Journal: JAMA network open
Published: January 25, 2022
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
Journal: PLoS medicine
Published: February 14, 2020
Evaluating Perceived Emergency Preparedness and Household Preparedness Behaviors: Results from a CASPER Survey in Fairfax, Virginia.
Journal: Disaster medicine and public health preparedness
Published: July 24, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function.
Journal: Neurology
Published: October 26, 2018
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.
Journal: Pharmacological research
Published: July 12, 2018
Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 17, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026